NSDL, India’s largest depository, is launching a ₹3,000 crore IPO in March, entirely as an offer for sale. Key banking stocks ...

Metsera's IPO raised $316.2 million, funding its obesity drug MET-097i, which shows promise with once-monthly dosing. Read ...

Investing.com -- Maze Therapeutics Inc (NASDAQ: MAZE ) received bullish coverage from multiple analysts, with Guggenheim, ...

Basel Medical Group (NASDAQ:BMGL) shares were up 4% in late afternoon trading Tuesday following a $9M U.S. initial public ...

Mirae Asset Mutual Fund has launched four new investment schemes, catering to two distinct themes—Initial Public Offerings ...

CeriBell Inc (CBLL) reports a 41% revenue increase and strategic expansions, despite facing increased operating expenses and supply chain tariffs.

Australia's securities regulator has urged the nation's stock exchange operator to be more proactive in making it easier and ...

Crowdfunding lets you bypass some of the gatekeeping associated with established lenders to get the money you need for your ...

Stock market participation in South India has grown significantly over the past decade as more people look for opportunities ...

Guggenheim has initiated coverage of Metsera (NASDAQ:MTSR) with a buy rating, citing the company's obesity drug candidates.

International Gemmological Institute India Ltd (IGIL), a newly-listed company, is set to pay an interim dividend to its ...

The company's board approved the opening of the issue on February 25 for the QIP of equity shares with a face value of Rs 2 ...